EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment effectiveness in vascular dementia and mixed dementia



Treatment effectiveness in vascular dementia and mixed dementia



Journal of the Neurological Sciences (203-204): 330, November 15




(PDF emailed within 1 workday: $29.90)

Accession: 035980135

Download citation: RISBibTeXText



Related references

Risperidone in the treatment of behavioural and psychological symptoms of dementia in patients diagnosed with vascular or mixed-type dementia. International Journal of Psychiatry in Clinical Practice 9(1): 45-51, 2005

Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. Journal of the Neurological Sciences 236(1-2): 43-48, 2005

Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia. Neurobiology of Aging 35(10): 2369-2381, 2015

Comparative evolution of Alzheimer disease, vascular dementia, and mixed dementia. Archives of Neurology 54(6): 697-703, 1997

Differential diagnosis in early onset of Alzheimers disease, vascular dementia and mixed dementia. European Journal of Neurology 10(Supplement 1): 158, September, 2003

Association of APOE alleles with vascular dementia, Alzheimers disease and mixed dementia in Korean patients. Journal of the Neurological Sciences (203-204): 340, November 15, 2002

An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia. Clinical Therapeutics 25(6): 1765-1782, June, 2003

Does perfusion CT enable differentiating Alzheimer's disease from vascular dementia and mixed dementia? A preliminary report. Journal of the Neurological Sciences 257(1-2): 114-120, 2007

The effect of galantamine on the quantitative EEG in vascular dementia and mixed dementia. Journal of the Neurological Sciences (203-204): 315, November 15, 2002

The role of the -427T/C apolipoprotein E promoter polymorphism in the pathogenesis of Alzheimer's disease, vascular dementia and mixed dementia. Journal of Neural Transmission 116(3): 339-344, 2009

Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients. Geriatrics & Gerontology International 15 Suppl 1(): 53-58, 2016

Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients. Journal of Alzheimer's Disease 50(3): 709-718, 2016

Is vascular dementia really Alzheimer's disease or mixed dementia?. Neuroepidemiology 15(6): 286-290, 1996

Serial position effect in a free recall task: differences between probable dementia of Alzheimer type (PDAT), vascular (VaD) and mixed etiology dementia (MED). Archives of Gerontology and Geriatrics 49 Suppl 1: 207-210, 2010

Vascular lesions in mixed dementia, vascular dementia, and Alzheimer disease with cerebrovascular disease: the Kurihara Project. Journal of the Neurological Sciences 322(1-2): 157-160, 2013